IP Verse

Methods For Rna Analysis - EP3090060

The patent EP3090060 was granted to Curevac on May 21, 2025. The application was originally filed on Dec 30, 2014 under application number EP14833130A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3090060

CUREVAC
Application Number
EP14833130A
Filing Date
Dec 30, 2014
Status
Patent Maintained As Amended
Apr 18, 2025
Grant Date
May 21, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MULLERNov 19, 2019-ADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS7074596
DESCRIPTIONWO03014450
DESCRIPTIONWO2006004648
DESCRIPTIONWO2008016473
DESCRIPTIONWO2008077592
DESCRIPTIONWO2008157688
DESCRIPTIONWO2009149253
DESCRIPTIONWO2011015347
DESCRIPTIONWO2013059475
INTERNATIONAL-SEARCH-REPORTWO0070039
INTERNATIONAL-SEARCH-REPORTWO2008077592
INTERNATIONAL-SEARCH-REPORTWO2012135805
INTERNATIONAL-SEARCH-REPORTWO2014152659
INTERNATIONAL-SEARCH-REPORTWO9640906
OPPOSITIONUS7074596
OPPOSITIONWO2014152659
OPPOSITIONWO2015188933
OPPOSITIONWO9640906

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- CAMPBELL T B ET AL, "The effect of structure in a long target RNA on ribozyme cleavage efficiency.", NUCLEIC ACIDS RESEARCH 15 DEC 1997, (19971215), vol. 25, no. 24, ISSN 0305-1048, pages 4985 - 4993-
EXAMINATION- M. FUKUDA ET AL, "A strategy for developing a hammerhead ribozyme for selective RNA cleavage depending on substitutional RNA editing", RNA, (20120713), vol. 18, no. 9, doi:10.1261/rna.033399.112, ISSN 1355-8382, pages 1735 - 1744, XP055128346
OPPOSITION- CUNNINGHAM, "New modalities in oncology: ribozymes", BUMC Proceedings, (20020000), vol. 15, pages 247 - 249-
OPPOSITION- KARIKO et al., "Lipofectin-aided cell delivery of ribozyme targeted to human urokinase receptor mRNA", FEBS Letters, (19940000), vol. 352, doi:10.1016/0014-5793(94)00914-7, pages 41 - 44, XP025576535
OPPOSITION- KHAN, "Ribozyme: A clinical tool", Clinica Chimica Acta, (20060000), vol. 367, doi:10.1016/j.cca.2005.11.023, pages 20 - 27, XP025058573
OPPOSITION- PENG et al., "Synthesis and Application of a Chain-Terminating Dinucleotide mRNA Cap Analog", Organic Letters, (20020000), vol. 4, no. 2, pages 161 - 164, XP055654130
OPPOSITION- KASHANI-SABET, "Ribozyme Therapeutics", JID Symposium Proceedings, (20021200), vol. 7, no. 1, pages 76 - 78, XP055654161
OPPOSITION- Kikovska E., Svard S. G., Kirsebom L. A., "Eukaryotic RNase P RNA mediates cleavage in the absence of protein", Proceedings of the National Academy of Sciences, National Academy of Sciences, US, US, (20070213), vol. 104, no. 7, doi:10.1073/pnas.0607326104, ISSN 0027-8424, pages 2062 - 2067, XP055778479
OPPOSITION- Duss Olivier et al, "A fast, efficient and sequence-independent method for flexible multiple segmental isotope labeling of RNA using ribozyme and RNase H cleavage", Nucleic Acids Research, Information Retrieval Ltd., GB, GB, (20101101), vol. 38, no. 20, doi:10.1093/nar/gkq756, ISSN 0305-1048, pages e188 - e188, XP055778484
OPPOSITION- Tanner N. Kyle, "Ribozymes: the characteristics and properties of catalytic RNAs", FEMS Microbiology Reviews, (19990601), vol. 23, no. 3, doi:10.1111/j.1574-6976.1999.tb00399.x, pages 257 - 275, XP055778489
OPPOSITION- NAKAMURA et al., "Design of Hammerhead Ribozymes that Cleave Murine Sry mRNA In Vitro and In Vivo", Journal of Reproduction and Development, (20060200), vol. 52, no. 1, pages 73 - 80, XP055654158
OPPOSITION- BASTUREA, "Research Methods for Detection and Quantification of RNA Modifications", Mater Methods, (20130100), vol. 3, page 186, XP055654157

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents